Arteriosclerosis, Thrombosis, and Vascular Biology. 1999;19:1250-1256
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
© 1999 American Heart Association, Inc.
Atherosclerosis and Lipoproteins |
Fish Intake, Independent of Apo(a) Size, Accounts for Lower Plasma Lipoprotein(a) Levels in Bantu Fishermen of Tanzania
The Lugalawa Study
From the Department of Medicine, University of Washington, Seattle (S.M.M., H.K.); and Centro Regionale dell'Aterosclerosi, Venezia (G.B.B., G.C.); Istituto di Scienze Farmacologiche, Università di Milano, Milano (C.G.); and Dipartimento di Medicina Clinica e Sperimentale, Università di Padova, Padova (E.C., M.P., P.P.), Italy.
Correspondence to Dr Paolo Pauletto, Dipartimento di Medicina Clinica e Sperimentale, Università di Padova, via Giustiniani 2, 35128 Padova, Italy, E-mail pauletto{at}ux1.unipd.it
 |
Abstract |
|---|
 Top Abstract IntroductionMethodsResultsDiscussionReferences |
|---|
Abstract—Plasma lipoprotein(a) [Lp(a)] levels are largely genetically determined by sequences linked to the gene encoding apolipoprotein(a) [apo(a)], the distinct protein component of Lp(a). Apo(a) is highly polymorphic in length due to variation in the numbers of a sequence encoding the apo(a) kringle 4 domain, and plasma levels of Lp(a) are inversely correlated with apo(a) size. In 2 racially homogeneous Bantu populations from Tanzania differing in their dietary habits, we found that median plasma levels of Lp(a) were 48% lower in those living on a fish diet than in those living on a vegetarian diet. Considering the relationship between apo(a) size and Lp(a) plasma concentration, we have extensively evaluated apo(a) isoform distribution in the 2 populations to determine the impact of apo(a) size in the determination of Lp(a) values. The majority of individuals (82% of the fishermen and 80% of the vegetarians) had 2 expressed apo(a) alleles. Additionally, the fishermen had a high frequency of large apo(a) isoforms, whereas a higher frequency of small isoforms was found in the vegetarians. When subjects from the 2 groups were matched for apo(a) phenotype, the median Lp(a) value was 40% lower in Bantus on the fish diet than in those on the vegetarian diet. A significant inverse relationship was also found between plasma n-3 polyunsaturated fatty acids and Lp(a) levels (r=-0.24, P=0.01). The results of this study are consistent with the concept that a diet rich in n-3 polyunsaturated fatty acids, and not genetic differences, is responsible for the lower plasma levels of Lp(a) in the fish-eating Bantus and strongly suggest that a sustained fish-based diet is able to lower plasma levels of Lp(a).
Key Words: fish diet • lipoprotein(a) • apolipoprotein(a) isoforms • polyunsaturated fatty acids
|
Introduction |
|---|
|
TopAbstractIntroductionMethodsResultsDiscussionReferences |
|---|
Lipoprotein(a), or Lp(a), is a distinct class of serum lipoprotein particles very similar in lipid and protein composition to LDL but additionally containing apolipoprotein(a) [apo(a)], a highly glycosylated protein covalently linked to the apo B-100 component of LDL.1 Apo(a) is formed by 3 different domains with >80% amino acid sequence identity with the corresponding kringle (K) 4, K5, and protease domains of plasminogen, a key component of the coagulation cascade.2 Unlike plasminogen, which possesses a single copy of K4, 10 basic K4 types, designated type 1 through 10, are present in apo(a). These K4 types are all present as a single copy except K4 type 2, which is present in multiple copies. The number of K4 type 2 copies is genetically controlled, varies considerably within and among individuals, and accounts for the high degree of apo(a) size heterogeneity.3 4 More than 34 apo(a) size isoforms have been detected in human plasma,5 and their distribution significantly varies among ethnic groups.6 7 The plasma concentration of Lp(a) also shows a high degree of heterogeneity in mean levels and in distribution across populations and is largely genetically controlled in both whites8 and blacks.9 A vast body of evidence has been presented on the relation of apo(a) size isoforms to Lp(a) concentrations in different ethnic groups.7 10 11 12 13 A large number of clinical studies (for a review, see Reference 1414 ) have provided strong evidence for an association between high Lp(a) levels and increased risk for coronary heart disease. Unlike the plasma level of LDL, which increases significantly on a high-fat diet, Lp(a) levels do not appear to be influenced significantly by dietary composition. However, there are conflicting results regarding the effect of changes in dietary fatty acid composition on Lp(a). Two supplementation studies with fish oil rich in n-3 polyunsaturated fatty acid (PUFA) resulted in a significant reduction in Lp(a) concentration,15 16 whereas Lp(a) levels were not decreased in another supplementation study.17 Additionally, no difference in Lp(a) levels was found in a small study comparing Eskimos, whose prevalent food intake is constituted by fish, and Danes.18
We have recently reported the results from the Lugalawa Study,19 which are consistent with a 38% lower mean plasma Lp(a) level in people living on a freshwater fish diet compared with those living on a vegetarian diet (19.9 versus 32.3 mg/dL, respectively). This study was carried out in a population of Bantu fishermen of Tanzania consuming 300 to 500 g (3 to 5 g of n-3 PUFAs) of freshwater fish per day, similar to the amount of fish consumed by the Eskimos. An important strength of the Lugalawa study, in addition to the large number of subjects (1308), was that the 2 populations belonged to the same ethnic group and had similar life styles and caloric intakes. Hence, the 2 populations were much more genetically homogeneous than Eskimos and Danes. However, owing to the well-documented contribution of apo(a) phenotype to plasma Lp(a) concentration,10 11 12 13 a direct evaluation of the distribution of apo(a) size polymorphs in the 2 populations was mandatory to define the role of the fish diet and the impact of genetic factors.
In the present study, we report on the apo(a) phenotype distribution between the 2 populations and the fact that differences in apo(a) size can only partly explain the observed difference in Lp(a) level. Our results strongly suggest that the fish diet plays a role in the determination of plasma Lp(a) levels.
|
Methods |
|---|
|
TopAbstractIntroductionMethodsResultsDiscussionReferences |
|---|
Study Population
As previously reported, we compared 2 Bantu populations of Tanzania,19 1 living on freshwater fish (n=622) in a village on Nyasa Lake and the other living mainly on a vegetarian diet (n=686) in a nearby farming area. Both populations are far removed from the Western life style, processed food or beverages are not readily available, and smoking is nearly absent. In a time span of 2 weeks, blood samples were drawn from the antecubital vein of each subject and collected in vials containing 0.6% EDTA. After immediate centrifugation, multiple plasma aliquots from each subject were collected and immediately frozen at -20°C to -25°C with use of a portable, butane-charged freezer. Samples were then flown to Italy and the United States on dry ice and thereafter stored at -80°C until use. Lp(a) levels were determined in Italy and apo(a) size isoforms in the United States. All of the analyses were completed within 10 months. Based on sample availability, apo(a) isoforms were determined in 618 subjects on the fish diet and 645 on the vegetarian diet. Plasma fatty acids were analyzed in 53 subjects of similar age and sex distribution from each population.
Lp(a) and n-3 PUFA Levels
Lp(a) level was determined by a 1-step sandwich
ELISA,20 a commercially available method (Immunozym Lp(a),
Immuno). Lp(a) values were calculated as total Lp(a) mass from a
standard curve constructed for each plate by using a commercially
available Lp(a) reference standard (Immuno). The levels of n-3 PUFAs
were measured by gas chromatography, as previously
described.21
Determination of Apo(a) Isoforms
The apo(a) size isoforms were determined by high-resolution
SDS-agarose gel electrophoresis followed by
immunoblotting as previously reported.5 We
have evaluated the relationship of the number of K4 domains, as
determined by pulsed-field gel electrophoresis,22 to the
mobility of the isoforms on SDS-agarose gel
electrophoresis5 and found that the logarithm of the K4
number was highly correlated with the mobility of the isoforms on
agarose gel.23 Therefore, the apo(a) isoforms are
designated by the relative number of K4 copies. This step is performed
by scanning the Western blot with a Hewlett-Packard ScanJet IICX with a
transparency adapter. A computerized approach is then introduced to
assign the K4 number by using Jandel Scientific Sigma Gel software in
the molecular weight mode. The same approach is used to determine the
amount of expression of each isoform in heterozygous subjects. In this
case, the program is used in the spot measurement mode.
Statistical Methods
Differences in isoform frequencies were assessed by the
Mann-Whitney U test and the 
2 test. At the
tails of the distribution curve (number of K4 repeats <14 and >31)
where only a small number of subjects was available (n=21 and n=19,
respectively), cells were pooled before computing 2 to
achieve a sufficient frequency to perform the analysis. To
compare the Lp(a) levels in the 2 populations, subjects were grouped
according to apo(a) isoform size, expressed in terms of the number of
K4 repeats, and compared by Friedman's nonparametric rank
test. To control for differences in apo(a) isoform frequencies between
the 2 Bantu populations, subjects between the villages were matched on
the basis of apo(a) phenotype. Heterozygous individuals were
matched for both isoforms. Differences in Lp(a) levels of these matched
pairs were assessed by the Wilcoxon matched-pairs test. The
contribution of apo(a) size to the variance of Lp(a) levels was
estimated by the R2 from the
ANOVAs.
|
Results |
|---|
|
TopAbstractIntroductionMethodsResultsDiscussionReferences |
|---|
As previously reported,19 we compared 2 Bantu populations from Tanzania highly differing in their dietary habits. Lp(a) and plasma lipid parameters of the 2 populations are summarized in Table 1
. The unadjusted
median difference in the plasma Lp(a) levels found between the 2 groups
was not modified by adjusting for age and alcohol or after matching
subjects for age, sex, and alcohol consumption. When analyzed
by sex, the same difference in Lp(a) values was found between men and
women from the 2 villages. On determination of apo(a) isoform size, the
majority of individuals (82% in the fish-diet population and 80% in
the vegetarian-diet population) had 2 expressed apo(a) alleles. As
evidenced in Figure 1, the population
living on the fish diet had a higher frequency of large apo(a) isoform
sizes while a higher frequency of small isoforms was found in the
population living on the vegetarian diet (P<0.001). If one
considers that an inverse correlation exists between apo(a) size and
Lp(a) concentration,10 the difference in Lp(a) values
between the 2 Bantu groups could potentially be accounted for by the
difference in apo(a) sizes. To evaluate this possibility, Lp(a) level
was evaluated as a function of apo(a) size. As presented in
Figure 2A, the respective number of K4
repeats was used for individuals expressing a single apo(a) allele
while the heterozygous individuals were analyzed in 2 separate
groups. In the majority of the heterozygous individuals in both
villages, 1 of the 2 apo(a) isoforms was predominantly expressed. We
define an isoform as predominantly expressed when it represents
>85% of the apo(a) as evaluated by scanning of the Western blot, as
detailed in Methods. If one further considers that in this case the
contribution of the second apo(a) isoform to Lp(a) value is very low,
statistical analyses were then performed with only the
predominantly expressed apo(a) size (Figure 2B). In the
relatively small number of heterozygous individuals with equally
expressed isoforms, we used the sum of the number of K4 repeats of the
2 isoforms (Figure 2C). Although both Bantu groups exhibited an
inverse relationship between apo(a) size and Lp(a) concentration, as
evidenced from the figure, the median Lp(a) for most of the apo(a) size
groupings was significantly higher in the vegetarian population. The
difference in median Lp(a) concentration between the 2 populations is
particularly evident in Figure B. Owing to the large number of
individuals in this group, the median Lp(a) values were significantly
higher in the vegetarians in all of the apo(a) size groupings. Overall,
the median Lp(a) value was 27 mg/dL in the vegetarian population and 14
mg/dL in the fish-diet population. This difference is highly
significant (P<0.001) and represents a 48%
difference in median Lp(a) concentration between the 2 groups. We
further evaluated the potential influence of the fish-based diet,
independent of apo(a) size, by focusing our analysis on
subjects from the 2 villages who could be matched according to the
expressed apo(a) alleles. A total of 410 subjects for each village,
corresponding to 
65% of the study population, were matched. Of
these, 96 pairs had a single expressed allele and 314 had 2
alleles. As presented in Table 2, median plasma Lp(a) levels were 40%
lower in people living on the fish diet than in those living on a
vegetarian diet (15.0 versus 25.0 mg/dL, P<0.001). However,
in heterozygous individuals, it cannot be excluded that the relative
level of expression of each isoform could be different between the
matched individuals, thus contributing differently to their Lp(a)
level. Therefore, we analyzed separately the matched
individuals with a single expressed allele and the matched
heterozygotes. As presented in Table 2, the median Lp(a)
level in heterozygotes was 33% lower in individuals on the fish diet
than in those on the vegetarian diet (17.0 versus 25.5 mg/dL,
P<0.001). In the group of individuals with a single
expressed allele, those on the fish diet had a median Lp(a) value
that was 47.8% lower than in vegetarians (12.0 versus 23.0 mg/dL,
P<0.001). Therefore, independently of the different
approaches used for the evaluation, differences in apo(a)
phenotypes explain only a minor part of the differences in
Lp(a) concentration. On the whole, the analysis of
R2 values for apo(a) size predicting
Lp(a) concentrations showed that the apo(a) phenotype predicted
23.0% of plasma levels in the vegetarian population versus only 14.4%
in the fishermen. If one considers that in heterozygous individuals the
2 alleles contribute differently to Lp(a) values, then the
R2 values for apo(a) phenotype
predicting Lp(a) concentration were separately calculated in
homozygotes and heterozygotes to account for this possibility (Table 3). For heterozygous individuals with
equally expressed isoforms, the sum of the number of K4 repeats of the
2 isoforms was used for analysis. As evident from Table 3, in each of the 3 groups, the contribution of apo(a) size to
Lp(a) value was significantly higher in the vegetarians. Furthermore,
in a sample representative of the 2 populations, a
significant, inverse relationship was found between plasma levels of
docosahexaenoic acid (DHA), eicosapentaenoic
acid (EPA), and total n-3 PUFAs and plasma Lp(a) levels (Table 4). Plasma Lp(a) levels were also
directly correlated with total n-6 PUFAs (r=0.207,
P=0.026) and indirectly with arachidonic
acid (AA; r=0.199, P=0.033). However, the whole
impact of n-6 PUFAs and AA on Lp(a) level seems to be weak, because the
ratios n-3/n-6 PUFAs, DHA/AA, EPA/AA, and n-3/AA were inversely related
to plasma Lp(a) values (Table 4). As expected, total
cholesterol levels were directly correlated with Lp(a)
plasma values in both populations (vegetarian diet, r=0.256,
P<0.0001, n=654; fish diet, r=0.213,
P<0.0001, n=618), whereas plasma triglycerides
were directly correlated with Lp(a) plasma levels in the fish diet
population (r=0.103, P=0.011, n=618) but not in
the vegetarian population (r=0.062, P=0.117,
n=645).
|
|
|
|
|
|
|
Discussion |
|---|
|
TopAbstractIntroductionMethodsResultsDiscussionReferences |
|---|
This is the largest population study on the dietary influence on Lp(a) levels thus far conducted and the only in which the contribution of apo(a) size to Lp(a) value differences has been rigorously and extensively evaluated. Although it is generally recognized that plasma Lp(a) levels are uninfluenced by common lipid-lowering therapy and only marginally affected by sex and age, some lowering effect has been achieved in 2 supplementation studies with n-3 PUFAs.15 16 On the other hand, a recent controlled trial17 did not show any change in Lp(a) levels. The discordant results provided by these studies may be explained by differences in the subjects' genetic backgrounds, in the degree of supplementation compliance, and by the possibility that a long-term consumption of n-3 fatty acid–rich food is required to achieve an effect on Lp(a) concentration. Additionally, in any of these studies, the biological variability of Lp(a), which has been reported to vary widely among individuals,24 has been taken under consideration. In this view, population studies comparing people living on a fish diet with an appropriate reference group would represent a sound approach to test whether or not the n-3 PUFAs are able to reduce plasma Lp(a) levels. The Lugalawa Study19 has provided a very good opportunity for studying the impact of a fish-based diet on several risk factors, including Lp(a), because of the homogeneity in race, age, and sex of the 2 populations studied. Additionally, the 2 populations are exposed to the same climate and share the same life style. Although it is very difficult, even in Western populations, to accurately assess physical activity, its level should not be substantially different in the 2 villages. In both environments, electricity and mechanical equipment are lacking, and both farmers and fishermen perform intense manual work. This lack of a significant difference in the level of physical activity between the 2 populations is particularly important because it has been previously shown that Lp(a) lowering with n-3 fatty acids was mostly effective in patients on an exercise program.25 Considering that apo(a) size plays an important role in the determination of Lp(a) levels, we conducted an extensive analysis of apo(a) isoform polymorphism. Our data elucidate the relative weight of genetic and dietary factors in the determination of Lp(a) levels. The strikingly lower Lp(a) level found in Bantus living on a fish diet compared with the Bantus living on a vegetarian diet persisted after adjusting/matching for age, sex, and alcohol consumption, the only epidemiological differences found between the 2 population groups. On the other hand, even though the 2 populations are racially homogeneous, we have found a significant difference in apo(a) isoform size distribution between the inhabitants of the 2 villages, probably due to differences between the founders of the 2 villages. Because of the inverse relationship between apo(a) size and Lp(a) levels in plasma,10 11 12 13 the significant prevalence of large Lp(a) molecules in the population living on the fish diet might have represented a valid explanation for the lower Lp(a) values found in the fishermen. Nevertheless, even after matching the subjects for apo(a) phenotypes, median Lp(a) values were still 40% lower in the fishermen than in the reference population. When the evaluation was performed again but only in matched individuals with a single expressed apo(a) size polymorphism, we found that the median plasma Lp(a) value in vegetarians was almost double that in individuals consuming a fish diet (23.0 versus 12.0 mg/dL). This striking 47.8% difference in median Lp(a) values between these 2 groups in which, unlike in the matched heterozygotes, we can exclude any confounding effect of possible differences in the degree of expression of the apo(a) alleles, further strengthens our conclusion that the fish diet represents an independent factor for lowering La(a) levels. Moreover, the distribution of apo(a) size in individuals expressing 1 or 2 isoforms accounted for 23.0% of plasma Lp(a) levels in the vegetarian Bantus, quite the same magnitude found in African Americans26 and in a Sudanese population.10 On the contrary, the apo(a) polymorphism explained only 12.1% or 14.5% in individuals expressing 1 or 2 apo(a) isoforms, respectively, of Lp(a) levels in people living on the fish diet, suggesting that environmental factor(s) may play a role. However, it should be taken into consideration that, in addition to apo(a) size, other yet-to-be-identified sequence differences linked to the apo(a) locus could contribute to differences in Lp(a) values,8 even though it is highly unlikely that they can entirely account for the striking difference in plasma Lp(a) concentration found between these 2 racially homogeneous populations. Recently, Kraft et al27 have reported that a C
T transition in the 5'
region of the apo(a) gene was associated with a significant reduction
in Lp(a) levels in 2 groups of blacks from Africa. However, this
polymorphism is relatively rare, and it is highly unlikely that a
significant proportion of fishermen are carriers of the C/T
polymorphism. Another possibility to consider is that apo(a)
alleles expressing low Lp(a) concentrations have been selectively
transmitted in the fishermen families. However, this hypothesis is
unlikely because intervillage marriage is very common. In intervillage
marriages, traditionally the women leave their village to join the
husband's family. As evidenced in Table 1
, no difference in
Lp(a) values between men and women was found in the 2 villages. This
suggests that a common environmental factor and not genetic differences
is responsible for the lower Lp(a) values in the Bantu fishermen. The inverse relationship found between plasma n-3 PUFAs and Lp(a) levels further endorses the view that a fish diet rich in n-3 PUFAs is the environmental factor responsible for the lower Lp(a) levels observed in our populations. On the other hand, the association between high intakes of both n-3 PUFAs and AA with the fish diet explains why there was also a weak inverse correlation between plasma AA levels and Lp(a). It is very likely, however, that AA does not affect Lp(a) levels, because the n-3/n-6 PUFA, DHA/AA, EPA/AA, and n-3 PUFA/AA ratios were all negatively correlated with Lp(a). In addition, it has recently been shown that a high intake of AA (1.7 g/d) by normal healthy subjects over a 50-day period does not modify lipoprotein distribution and apoprotein levels.28 Finally, it is of interest to note that in the fish-diet population, but not in the vegetarians, a direct relationship exists between plasma Lp(a) and triglyceride levels, which is likely to be due to the lowering effect of n-3 PUFAs on both parameters. The mechanisms linking high fish intake and lower Lp(a) levels in plasma are unclear, because it is unknown at this time whether n-3 PUFAs affect apo(a) synthesis or metabolism. It has been suggested29 that an appreciable proportion of n-3 fatty acids may directly enter the portal vein system, producing profound effects on liver function, such as a marked reduction in serum triglycerides. It can be speculated that the n-3 fatty acids may lower the rate of apo(a) synthesis and/or secretion from the liver. Additionally, it has been hypothesized that high levels of n-3 fatty acids may result in an impaired assembly of apo(a) with LDL or in enhanced catabolism.25 However, to confirm these hypotheses, further studies are required to elucidate the molecular mechanisms by which n-3 PUFAs decrease the levels of Lp(a) in plasma.
In conclusion, this is the first population-based, genetically controlled study to provide evidence that the dietary content of n-3 PUFAs is able to interfere with the expression of the atherogenic Lp(a) lipoprotein.
|
Acknowledgments |
|---|
This work was supported by National Institutes of Health (Bethesda, Md) grant HL30086 (to Dr Marcovina). The Lugalawa Study was supported by the World Health Organization (Geneva, Switzerland) and the Biomedical Association for Vascular Research (Padova, Italy). We thank Jean Mernaugh for technical assistance in the determination of apo(a) size isoforms.
Received July 28, 1998; accepted September 25, 1998.
|
References |
|---|
|
TopAbstractIntroductionMethodsResultsDiscussionReferences |
|---|
- Koschinsky ML, Marcovina SM. Lipoprotein(a): structural implications for pathophysiology. Int J Clin Lab Res. 1997;27:14–23.[Medline] [Order article via Infotrieve]
- McLean JW, Tomlinson JE, Kuang WJ, Eaton DL, Chen EY, Fless GM, Scanu AM, Lawn RM. cDNA sequence of human apolipoprotein(a) is homologous to plasminogen. Nature. 1987;330:132–137.[Medline] [Order article via Infotrieve]
-
Lackner C, Cohen JC, Hobbs HH. Molecular definition of
the extreme size polymorphism in apolipoprotein(a). Hum Mol
Genet. 1993;2:933–940.
[Abstract/Free Full Text] -
van der Hoek YY, Wittekoek ME, Beisiegel U, Kastelein
JJ, Koschinsky ML. The apolipoprotein(a) kringle IV repeats which
differ from the major repeat kringle are present in variably-sized
isoforms. Hum Mol Genet. 1993;2:361–366.
[Abstract/Free Full Text] - Marcovina SM, Zhang ZH, Gaur VP, Albers JJ. Identification of 34 apolipoprotein(a) isoforms: differential expression of apolipoprotein(a) alleles between American blacks and whites. Biochem Biophys Res Commun. 1993;191:1192–1196.[Medline] [Order article via Infotrieve]
- Kraft HG, Lingenhel A, Pang RW, Delport R, Trommsdorff M, Vermaak H, Janus ED, Utermann G. Frequency distributions of apolipoprotein(a) kringle IV repeat alleles and their effects on lipoprotein(a) levels in Caucasian, Asian, and African populations: the distribution of null alleles is non-random. Eur J Hum Genet. 1996;4:74–87.[Medline] [Order article via Infotrieve]
- Marcovina SM, Albers JJ, Wijsman E, Zhang Z-H, Chapman NH, Kennedy H. Differences in Lp(a) concentrations and apo(a) polymorphs between black and white Americans. J Lipid Res. 1996;37:2569–2585.[Abstract]
- Boerwinkle E, Leffert CC, Lin J, Lackner C, Chiesa G, Hobbs HH. Apolipoprotein(a) gene accounts for greater than 90% of the variation in plasma lipoprotein(a) concentrations. J Clin Invest. 1992;90:52–60.
- Mooser V, Scheer D, Marcovina SM, Wang J, Guerra R, Cohen J, Hobbs HH. The apo(a) gene is the major determinant of variation in plasma Lp(a) levels in African Americans. Am J Hum Genet. 1997;61:402–417.[Medline] [Order article via Infotrieve]
- Sandholzer C, Hallman DM, Saha N, Sigurdsson G, Lackner C, Csaszar A, Boerwinkle E, Utermann G. Effects of the apolipoprotein(a) size polymorphism on the lipoprotein(a) concentration in 7 ethnic groups. Hum Genet. 1991;86:607–614.[Medline] [Order article via Infotrieve]
- Helmhold M, Bigge J, Muche R, Mainoo J, Thiery J, Seidel D, Armstrong VW. Contribution of the apo(a) phenotype to plasma Lp(a) concentrations shows considerable ethnic variation. J Lipid Res. 1991;32:1919–1928.[Abstract]
- Rainwater DL. Genetic basis for multimodal relationship between apolipoprotein(a) size and lipoprotein(a) concentration in Mexican-Americans. Atherosclerosis. 1995;115:165–171.[Medline] [Order article via Infotrieve]
- Gaw A, Boerwinkle E, Cohen JC, Hobbs HH. Comparative analysis of the apo(a) gene, apo(a) glycoprotein, and plasma concentrations of Lp(a) in three ethnic groups: evidence for no common `null' allele at the apo(a) locus. J Clin Invest. 1994;93:2526–2534.
- Marcovina SM, Koschinsky ML. Lipoprotein(a): structure, measurement, and clinical significance. In: Rifai N, Warnick GR, Dominiczak MH, eds. Handbook of Lipoprotein Testing. Washington, DC: American Association of Clinical Chemistry Press; 1997:283–313.
- Haglund O, Mehta JL, Saldeen T. Effects of fish oil on some parameters of fibrinolysis and lipoprotein(a) in healthy subjects. Am J Cardiol. 1994;74:189–192.[Medline] [Order article via Infotrieve]
- Beil FU, Terres W, Orgass M, Greten H. Dietary fish oil lowers lipoprotein(a) in primary hypertriglyceridemia. Atherosclerosis. 1991;90:95–97.[Medline] [Order article via Infotrieve]
- Eritsland J, Arnesen H, Berg K, Seljeflot I, Abdelnoor M. Serum Lp(a) lipoprotein levels in patients with coronary artery disease and the influence of long-term n-3 fatty acid supplementation. Scan J Clin Lab Invest. 1995;55:295–300.[Medline] [Order article via Infotrieve]
- Gerdes LU, Schmidt EB, Klausen IC, Kristensen SD, Ernst E, Faergeman O, Dyerberg J. Plasma concentration levels of apolipoprotein A-I, apolipoprotein B and lipoprotein(a) in Greenland Inuit (Eskimos). J Intern Med. 1992;231:623–625.[Medline] [Order article via Infotrieve]
- Pauletto P, Puato M, Caroli MG, Casiglia E, Munhambo AE, Cazzolato G, Bittolo Bon G, Angeli MT, Galli C, Pessina AC. Blood pressure and atherogenic lipoprotein profiles of fish-diet and vegetarian villagers in Tanzania: the Lugalawa study. Lancet. 1996;348:784–788.[Medline] [Order article via Infotrieve]
- Kostner GM, Gries A, Pometta M, Molinari E, Pichler P, Aicher H. Immunochemical determination of lipoprotein Lp(a): comparison of Laurell electrophoresis and ELISA. Clin Chim Acta. 1990;188:187–192.[Medline] [Order article via Infotrieve]
- Marangoni F, Angeli MT, Colli S, Eligini S, Tremoli E, Sirtori CR, Galli C. Changes of n-3 and n-6 fatty acids in plasma and circulating cells of normal subjects after prolonged administration of 20:5 (EPA) and 22:6 (DHA) ethyl esters and prolonged washout. Biochim Biophys Acta. 1993;1210:55–62.[Medline] [Order article via Infotrieve]
- Lackner C, Boerwinkle E, Leffert CC, Rahmig T, Hobbs HH. Molecular basis of apolipoprotein(a) isoform size heterogeneity as revealed by pulsed-field gel electrophoresis. J Clin Invest. 1991;41:246–255.
-
Marcovina SM, Hobbs HH, Albers JJ. Relation between
number of apolipoprotein(a) kringle 4 repeats and mobility of isoforms
in agarose gel: bases for a standardized isoform nomenclature.
Clin Chem. 1996;42:436–439.
[Abstract/Free Full Text] -
Marcovina SM, Gaur VP, Albers JJ. Biological
variability of cholesterol, triglyceride, low-
and high-density lipoprotein cholesterol, lipoprotein(a),
and apolipoproteins A-I and B. Clin Chem. 1994;40:574–578.
[Abstract/Free Full Text] - Hermann W, Bierman J, Kostner GM. Comparison of effects of n-3 to n-6 fatty acids on serum levels of lipoprotein(a) in patients with coronary artery disease. Am J Cardiol. 1995;76:459–462.[Medline] [Order article via Infotrieve]
-
Marcovina SM, Albers JJ, Jacobs DR Jr, Perkins LL,
Lewis CE, Howard BV, Savage P. Lipoprotein(a) concentrations and
apolipoprotein(a) phenotypes in Caucasians and African
Americans: the CARDIA Study. Arterioscler Thromb. 1993;13:1037–1045.
[Abstract/Free Full Text] -
Kraft H-G, Windegger M, Menzel HJ, Utermann G.
Significant impact of the +93 C/T polymorphism in the
apolipoprotein(a) gene on Lp(a) concentrations in Africans but not in
Caucasians: confounding effect of linkage disequilibrium. Hum Mol
Genet. 1998;7:257–264.
[Abstract/Free Full Text] - Nelson GJ, Smith PC, Bartolini G, Kelley DS, Phinney SD, Kyle D, Silbermann S, Schaefer EJ. The effect of dietary arachidonic acid on plasma lipoprotein distribution, apoproteins, blood lipid levels and tissue fatty acid composition in humans. Lipids. 1997;32:427–433.[Medline] [Order article via Infotrieve]
- Nelson GJ, Ackman RG. Absorption and transport of fat in mammals with emphasis on n-3 polyunsaturated fatty acids. Lipids. 1998;23:1005–1014.
This article has been cited by other articles:
 |
|
 |
|
  E. Anuurad, J. Rubin, A. Chiem, R. P. Tracy, T. A. Pearson, and L. Berglund High Levels of Inflammatory Biomarkers Are Associated with Increased Allele-Specific Apolipoprotein(a) Levels in African-Americans J. Clin. Endocrinol. Metab., April 1, 2008; 93(4): 1482 - 1488. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Meinertz, K. Nilausen, and J. Hilden Alcohol-Extracted, but Not Intact, Dietary Soy Protein Lowers Lipoprotein(a) Markedly Arterioscler. Thromb. Vasc. Biol., February 1, 2002; 22(2): 312 - 316. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Hernández, P. Chacón, L. García-Pascual, and R. Simó Differential Influence of LDL Cholesterol and Triglycerides on Lipoprotein(a) Concentrations in Diabetic Patients Diabetes Care, February 1, 2001; 24(2): 350 - 355. [Abstract] [Full Text]
|
|
|
|
 |
|
 K. J. Harjai Potential New Cardiovascular Risk Factors: Left Ventricular Hypertrophy, Homocysteine, Lipoprotein(a), Triglycerides, Oxidative Stress, and Fibrinogen Ann Intern Med, September 7, 1999; 131(5): 376 - 386. [Abstract] [Full Text] [PDF]
|
|
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||